| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.002 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |